Share Prophets

Wednesday 20 June 2018 | ShareProphets: The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares



Results

Search articles by EPIC code

Premaitha – deal with Coastal Genomics, not the normal RNS but still STRONG BUY, new target price

2018-06-13 02:51:31

We are getting increasingly used to Premaitha (NIPT) announcing more and more large non-UK distribution agreements. And fear not there will be much more on that front in the weeks and months that lie ahead. It will be a hot summer for Premaitha and for we loyal shareholders. But, for now, there is something a bit different.

Premaitha - Indian Deal, a big deal. Strong Buy

2018-06-07 08:00:00

The rehabilitation of Premaitha Health (NIPT) continues. The latest news is from India where there is not even a whiff of a patent challenge from Illumina and where our boys have signed a 3-year agreement with one of the most advanced clinical laboratory groups in the country to provide a bespoke, high quality and scaleable NIPT solution.

Premaitha - placing, trading update, all good good good

2018-05-16 00:09:50

Let's declare an interest first. FIML, a company owned via a Trust by dependents of Tom Winnifrith, took part in the placing at 4.5p but was scaled back so topped up with market purchases at 6.9p.

FinnCap - Premaitha at 7p worth 12p

2018-05-15 05:35:56

It is the house broker so not impartial. I think the target for Premaitha (NIPT) is too low and bought more shares this morning in the secondary market. But here is the Finncap take in a 20 page note:

Premaitha Health – Egypt IONA test agreement further adds to positive operating momentum

2018-02-20 01:20:11

Premaitha Health (NIPT) has announced an exclusive partner agreement to offer the IONA non-invasive prenatal test across Egypt and a first Egyptian customer…

Premaitha gets clearance to sell IONA in Brazil - a strong buy

2018-02-06 02:20:15

Premaitha Health (NIPT) has announced that its IONA test has been approved by Brazil's regulatory authority, Agência Nacional de Vigilância Sanitária (ANVISA), for sale as an in vitro diagnostic test.

Premaitha Health - granted leave to appeal against Illumina court judgment - BUY

2018-01-26 01:31:43

Updating on Premaitha Health (NIPT) earlier in the week we noted an up to £2.1 million loan facility agreement to fund costs related to the ongoing Illumina litigation and that a Form of Order hearing is scheduled to take place early this week. The shares are currently rising towards 5p on the back of a UK High Court grants right to appeal announcement from the company…

Premaitha Health – further loan facility to deal with Illumina legal costs

2018-01-23 05:05:36

On last month-announced results for its half year ended 30th September 2017, we noted Premaitha Health (NIPT) currently looking at positive pre-litigation cashflows, but that there remained risk of low cash headroom or even a cash shortfall including if further litigation-related costs are required. There’s now a Secured loan facility agreement with Thermo Fisher announcement.

Premaitha Health – interims, it’s far from gloomy

2018-01-06 10:42:01

Results for its half-year ended 30th September 2017 from Premaitha Health (NIPT) contained some bad news – which sees the shares currently at a depressed little more than 5p, but also many more positive aspects…

Premaitha - new partner signed in Asia and there will be more

2017-11-24 09:00:35

After the Illumina legal setback for Premaitha (NIPT) we suggested that the cost of that setback was very manageable – a maximum of less than £2 million is what we hear – and that the underlying business is doing very well. That view is reaffirmed by latest news.

Premaitha loses Illumina court challenge - bad news but not a sell, indeed....

2017-11-22 02:10:29

This is not the news we Premaitha (NIPT) shareholders wanted and it is clearly bad news. The question is how bad? The UK High Court has upheld three patent claims made by Illumina against Premaitha.

Premaitha - Good News from Brazil but it's the High Court that matters

2017-09-05 07:55:14

Premaitha (NIPT) has announced that it has been approved for Brazilian Good Manufacturing Practice for the company's IONA test by Brazil's regulatory authority, the Agência Nacional de Vigilância Sanitária. Jolly good news and it strengthens the story, but it is not the elephant in the room is it?

Premaitha - new Thermo Fisher loan: sends strong message to Illumina: BUY

2017-07-16 02:44:21

Premaitha Health (NIPT) has announced that it has entered into a further extension of the investment agreement with Thermo Fisher Scientific  announced on 14 December 2015 and extended as announced on 23 September 2016. This is good news.

Premaitha - Court action begins this week - BUY

2017-07-07 06:02:01

And so after more than a year of huff and puff and fascist corporate bullying by US giant Illumina, the High Court action with Premaitha (NIPT) starts tomorrow. Premaitha says:

Premaitha - Indian news but what about the cowboys?

2017-06-09 03:40:25

Premaitha (NIPT) has updated investors on its progress in India where it claims now to have representation in 9 of the 15 most populous states with several of the largest nationwide pathology laboratory groups running Yourgene's NIPT workflow in-house.

Premaitha - full year trading statement: BUY

2017-05-18 02:08:06

Premaitha (NIPT) has updated on trading in the year to March 31 2017. Of course, what matters is not historic trading but the future, that is to say the patent challenge by US corporate fascist bully-boys Ilumina. However, some numbers do matter...

Premaitha - puts Swiss distributor Genoma into bankruptcy: BUY

2017-05-13 01:43:18

The issue with Genoma was flagged up in the interims pre-Christmas. It owes Premaitha (NIPT) £750,000. That debt looks like a bad debt because the Swiss company has - despite its parent company concluding a fundraise - been having financial issues. So Premaitha has gone to court and had Genoma made bankrupt.

Premaitha - More Good News: BUY

2017-02-28 01:18:46

We have a new share tip out at 2PM today but here is one which has not dazzled yet. We tipped it an an 18p offer, the shares are now 11.75p-12.5p but we hope readers took our advice and averaged down at as low as 7.5p But the stock is now on a roll and is still cheap. You can catch our new hot tip for just £5 HERE but pro tem back to Premaitha (NIPT).

Premaitha at 10.6p worth 18p says FinnCap - new research note

2017-02-20 07:41:24

The fragrant Alice Lane, a foxy young brokerette who apparently I once reduced to tears by being so beastly, is this morning disseminating the latest FinnCap note on Premaitha (NIPT) to clients. Since it is bullish I am happy to make it up to Alice by exposing this high quality research to a wider audience, especially since we own more than a few shares. By way of balance i should say that FinnCap is house broker and therefore utterly partial and you can feel free to ignore every word of this report.

Premaitha share issue - not a grovel sort of placement: BUY

2017-02-17 09:16:18

After two pieces of good news in as many days you do not need to be cynic of the year to expect a placing. But this is not a placing as in the company's broker goes and grovels to fund managers. Premaitha (NIPT) was approached and asked it wanted cash and so has taken £1.487 million at 8.75p per share from Harwood Capital

Premaitha - some good news from Southern Europe: Buy

2017-02-13 01:21:35

After a longish period of radio silence Premaitha (NIPT) has served up news of a number of new customers through its distribution network in Southern Europe.

Premaitha - good news from out East: Buy

2016-11-24 05:16:26

Premaitha (NIPT) has announced that its Thai distributor. Geneplus, has formally signed an agreement to offer the Company's IONA test in the Center for Medical Genomics (CMG), Ramathibodi Hospital, Mahidol University, partnering with the Thailand Center of Excellence for Life Sciences.

The Vexed Moral Question of Share-Buying -2

2016-11-03 01:00:45

Hello Share Keepers. There were interesting responses to my piece which followed Uncle Tom’s thoughts on Premaitha (NIPT). And there’s probably a bit more to say on the wider picture of buying shares in companies which are doing things you may be uneasy about for your own personal, moral reasons.

Free Iona tests on NHS - good news for Premaitha: Buy

2016-11-02 06:06:11

The Government has announced that as of 2018 it will offer free Non Invasive Prenatal Tests (NIPT) for Downs to women deemed to be at high risk - that is those over 38 years old. Right now it costs you £180 to have an NIPT test rather than an invasive one which has a 1% chance of killing your baby.

The Vexed Moral Dimension of Share Shifting and How to Sleep At Night

2016-11-01 01:00:24

Hello Share Collectors. There is a Mel Gibson film being praised at the moment. It tells the story of a soldier in the Second World War who refused to kill, yet still went into battle to save his colleagues.

Premaitha - The Guardian reports that the NHS will offer free NIPT tests from 2018: what about morality?

2016-10-30 06:55:19

The Guardian has reported that as of 2018 the NHS will offer free non invasive tests for Downs to all at risk women. This is great news for AIM listed Premaitha (NIPT) which is a leading provider of such tests. For it there is a clear financial gain but there is an ethical element here which as a shareholder but also a recent father causes me some issues.

Premaitha - upbeat AGM Statement: buy

2016-10-30 04:48:27

And now to what has not, to date, been a good share tip. But it will be and at 9p-9.25p you should average down in Premaitha (NIPT) and buy. The AGM statement this week from chairman Adam Reynolds was upbeat.

Premaitha - FY Results: numbers academic its the statement that counts: Buy

2016-10-09 00:34:13

Premaitha (NIPT) announced late last week its results for the year to March 31 2016. Given the pace of events here these historic numbers do not mean that much but for the record:

Premaitha - new loan facility - this is the start of more good news: Buy

2016-09-27 06:53:56

Apologies for the delay in commenting on this RNS which landed on Friday. We wanted to speak to Adam Reynolds and we have now done so. This is just the start of the good news and ahead of results tomorrow Premaitha (NIPT) shares are a buy.

Premaitha - God Bless the EU: Buy

2016-07-10 09:36:56

After 44 years of membership, at last one good thing has come out of the EU for Britain. God bless the Evil Empire. Premaitha (NIPT) has provided an update on its legal battles with US bully boys Illumina.

Premaitha at 8.6p worth 20p says FinnCap in initiation note

2016-06-06 02:10:23

Finncap is joint broker to Premaitha (NIPT) so is clearly biased. We own shed loads of the shares so are we. So feel free to ignore it all but here is FinnCap's pretty detailed initiation of coverage note.

Video: Dragon's Den 3 from UK Investor Show - Premaitha, Asiamet et al

2016-05-17 00:24:33

In the third Dragon's Den session at UK Investor Show the Dragons were myself (Tom Winnifrith) Steve Moore and Brian Kinane. The companies pitching were United Cacao (CHOC), Premaitha (NIPT), ECR Minerals (ECR), Forbidden Technology (FBT) and Asiamet Resources (ARS)

Premaitha - good news on patent dispute, the shares should double

2016-04-22 01:41:08

Although the twit who handles PR for Premaitha (NIPT) has again contrived to confuse the issue with some garbled press releases this morning there is actually some good news. Fire the idiot PR man and investors could get excited as they discover what is really going on.

Premaitha – does the company need to sack its PR too?

2016-04-18 06:49:24

This is an utter shambles from AIM-listed Premaitha (NIPT). If you are going to go to the trouble and (shareholders’) expense of putting out an RNS to highlight some paid-for ramping research by Hardman, at least get the bloody RNS right! Tom Winnifrith has already had a furious rant that the company’s Broker, finnCap, should be sacked. Is the same true of the PR genii behind today’s abject efforts?

Premaitha - all sorts of fun and games: buy

2016-04-14 01:32:35

The shares of Premaitha (NIPT) have been all over the shop since what was a cracking year end trading statement on Monday. The reason is the cackhanded disposal of Rupert Lywood's remaining 17.9% stake. We thought he was locked in following his last dump on 9 March and a statement signed off by broker Finncap. Weasel words. His shares were placed by Finncap at just 6.5p with directors taking some and solid institutions Helium, Henderson and Hargreave Hale taking the rest. The overhang is now gone but boy has it crushed the shares. Without Lywood's "assistance" since last summer we think the shares would be 20p today. But he is now out of the picture.

Premaitha - it is all happening - share weakness explained

2016-03-11 02:55:03

Tom Winnifrith was an insider which restricted him from explaining why shares in Premaitha (NIPT) have been weak of late. Now you can see. The company's largest shareholder Rupert Lywood is a total 100% prat

Premaitha Company chat - those 2 sets of forecasts and more: buy

2016-02-14 02:16:50

The wider market is taking a bath and Premaitha (NIPT) shares are not immune to this now at 14.5p-15p. But there are also a couple of points which are company specific and in that vein we have had a detailed chat with the company on Friday.

Premaitha - good Leads from Leeds, buy

2016-02-04 02:15:53

Premaitha Health (NIPT) has announced a partnering with Leeds Teaching Hospitals NHS Trust - one of the largest in England - to provide a private non-invasive prenatal screening service for pregnant women in the region.

Premaitha contract wins & litigation timetable: buy

2016-01-31 09:37:00

Premaitha Health (NIPT) has announced further international expansion of its customer base and updated on UK litigation timing

Premaitha - good news from the NHS

2016-01-19 08:04:40

Premaitha Health (NIPT) has welcomed the UK National Screening Committee recommendation to routinely offer non-invasive prenatal testing on the NHS to high-risk pregnant women, noting “this is the first time that non-invasive prenatal testing will be routinely available to high risk pregnant women on the NHS and sets a precedent that we expect other countries to follow in the near future” and that“Premaitha is uniquely positioned to bring the benefits of non-invasive prenatal testing to the NHS”

Zak Mir's Great Request Show: Dechra Pharma, Frontera Resources & Premaitha Health

2016-01-17 04:55:05

Today at the request of my small handful of readers I look at shares in Dechra Pharma (DPH), Frontera Resources (FRR) and Premaitha Health (NIPT) setting share price targets for all three stocks.

Premaitha - Illumina are pests but the stance is buy

2016-01-09 09:46:26

Premaitha Health (NIPT) has noted an announcement from Illumina, Inc. of patent infringement suits against Premaitha's customer in Poland and Ariosa Diagnostics, a subsidiary of Roche, and their customer, The Doctors Laboratory, in the UK, while reiterating that it “continues to make a robust defence against earlier claims by Illumina and the board is confident that the IONA test does not infringe the patents as claimed in the earlier cases or in relation to today's announcement”


Tom Winnifrith's share tips of the year No 7 - Buy Premaitha at 18.5p - target 30p

2016-01-03 11:31:07

Ok this was one of my less successful share tips of the year for 2015 but this time it really will come good. That will be the prompt for guffaws of laughter from Wildes, who is currently sitting on a sinking lifeboat from the doomed SS LGO Energy. But he who laughs last... 

Zak Mir's Great Request Show: Anglo Asian Mining, Fastnet Equity, Premaitha Health

2015-12-22 04:10:17

If you want me to analyse a stock for you just drop me a line at [email protected] - Today I look at shares in Anglo Asian Mining (AAZ), Fastnet Equity (FAST) and Premaitha Health (NIPT) setting share price targets for all three stocks.

Premaitha - interims and more: buy at up to 24p

2015-12-20 01:13:28

Premaitha Health (NIPT) has announced results for its half year ended 30th September 2015, that “we have a good pipeline of prospects and we are confident that we will continue to build our revenues throughout the forthcoming period” and an up to £5 million loan facility from $17 billion revenue science company Thermo Fisher.

Video: Adam Reynolds How To Invest in Shells presentation at Gold & Bears November 2015

2015-12-14 04:00:23

And now it is the shellmeister Adam Reynolds, he of Optibiotix (OPTI), New World Oil & Gas (NEW) and Premaitha (NIPT) fame presenting at Gold & Bears. A full interview by the Sith Lord with Adam is out today and can be read HERE. Enjoy the video.

Premaitha - 3 year vote of confidence from France: buy

2015-12-03 07:27:54

Premaitha Health (NIPT) has announced Adgenix as its exclusive distributor in France and that Adgenix has already signed up its first laboratory customer - with a “contract for a minimum of three years to supply LaboSud with the IONA test”

Premaitha: stunning test results what we need are contracts, wont be long

2015-11-14 02:26:32

Premaitha (NIPT) has announced some pretty stunning results from an independent test of its IONA test published in the Journal of Ultrasound, Obstetrics in Gynecology.   Dam, why did we not get ahead of the news and subscribe to that must read publication? It sounds gripping stuff.

Zak Mir's Great Request Show: Ferrexpo, Paragon Entertainment & Premaitha Health

2015-10-27 03:27:27

If you want me to analyse a stock for you just drop me a line at [email protected] - Today I look at shares in Ferrexpo (FXPO), Paragon Entertainment (PEL), Premaitha Health (NIPT), and setting share price targets for all three stocks

Premaitha - average down - buy

2015-10-11 07:59:02

Premaitha Health (NIPT) has announced an agreement with the leading distributor of scientific products in Greece (Antisel SA) to provide its IONA test to clinical laboratories in the region and that it has been informed that American company Illumina, Inc. has added a third patent to its suit against it. Buy, sell or hold?

Buy Premaitha Health at a 20p offer, 
says Tom Winnifrith



2015-09-19 02:01:17

This was not going to be my tip in the recently published book "The Magnificent 7" which you can download for free HERE. I was set to tip Optibiotix (OPTI) at c40p. Unfortunately for you (but fortunately for me since we own shares in the company) the share price has raced ahead to a 48p offer. I still think that they could head much higher and Zak Mir reckons that Optibiotix shares will be 60p by October. I think, that is what a chartist terms a long term view.



Premaitha: Buy at 25p on contract news - target 31p says Panmure Gordon

2015-06-22 04:44:38

Panmure Gordon is house broker to Premaitha (NIPT) so take its morning note with a pinch of salt. It is paid to say buy. However for what it is worth here is its analysis of today's news and its forecasts.

Premaitha - NHS testing IONA - this is potentially enormous

2015-06-08 01:43:08

The Daily Mail & BBC this weekend ran stories about how the NHS was doing trials which would see all pregnant women getting a non invasive pre-natal test for down's syndrome. The Mail piece sums it up HERE

Buy Premaitha at a 26.75p offer - target 35p to sell by September

2015-06-05 03:26:29

We have tipped Premaitha (NIPT) before and our readers have banked big gains on it Now the time is right for re-entry and so this Adam Reynolds biotech play was our second May share tip of the month. 

Zak Mir's Great Request Show: JKX Oil & Gas, Premaitha Health, RapidCloud International.

2015-05-24 02:53:00

If you want me to analyse a stock for you just drop me a line at [email protected] - Today I look at JKX Oil & Gas, Premaitha Health and RapidCloud International.

Why I’m sticking with Premaitha – cracking news today, BTW

2015-03-23 07:20:36

Last week was a bit of a stomach churner for Premaitha (NIPT). The shares zoomed for about 30 minutes as it announced a stunning deal to commercialise its IONA test. They the tanked as a US giant launched a patent infringement case. Today they are zooming – up 37% at 24p – but I am not selling. In fact I am just kicking myself for not buying more at 16p a week ago!

Premaitha – how high could it go in the Long Term? I am asked

2015-02-09 04:27:26

In short: I am buggered if I know.  The Nifty Fifty tipped the shares at a 15p offer and out target to sell is 30p as noted HERE at the weekend. The shares are now 24.5p to sell.

Premaitha launches Iona test as it gets CE mark ..shares up but more to come

2015-02-08 04:47:49

A few weeks earlier than we had expected, Premaitha Health (NIPT) has announced that it has received CE-mark approval for its Iona test and will therefore launch it commercially at once. This is good news and the shares are now 23.5p – 24.5p.

Premaitha - good news but not quite the sealed deal yet

2015-01-31 09:07:57

Premaitha (NIPT) has announced that it is almost there on getting the crucial CE-mark for its IONA test. It has passed two key milestones including ISO 13485:2003 certification  which confirms that Premaitha's quality management system has been approved as applicable to the design, development and manufacture of in vitro diagnostic reagents and associated software for non-invasive assessment of genetic abnormalities.

Tom Winnifrith’s sixth share tip of the year 2015, buy Premaitha at a 19.5p offer

2015-01-01 05:11:41

One of the reasons that capitalism works while the alternative is doomed to fail is that failing companies can reinvent themselves.

Premaitha Results and share price - buy at up to 19p ahead of Jan news

2014-12-20 04:34:40

Shares in Premaitha (NIPT) have slipped back to 17-17.5p as part of the pre Christmas non Santa rally. Results for the 7 months to 30 September were largely a Vialogy tidy up and were no great shakes. It is what will happen in 2015 that matters.

Roche buys Ariosa – Panmure’s bullish Read across for Premaitha

2014-12-02 09:39:33

Today Pharma giant Roche has snapped up a California based form Ariosa which is big in what is termed NIPT. Panmure Gordon, house broker to Premaitha (NIPT) reckons this has a clear read across for its AIM listed client. In a note sent out today it writes:

Premaitha - good AGM statement: Buy

2014-11-06 07:36:45

Premaitha Health (NIPT) has updated investors attending its AGM that it believes its lead product “remains on target to be the first regulated CE marked ‘in vitro’ diagnostic product in the rapidly growing market for non-invasive prenatal screening”.

Premaitha at 18.75p – Panmure Initiates coverage with a buy stance and 23p target (detailed note)

2014-10-30 09:22:25

Panmure Gordon, house broker to Premaitha (NIPT) has initiated its coverage of the stock at 18.75p. It rates the shares as a buy with a 23p target, based on applying a 30% discount to a peer group analysis. The note from analyst Mike Mitchell is a detailed 23 page study.

Video of Premaitha presentation at the ShareProphets Seminar

2014-10-09 07:15:51

Heck, I am biased, we own these shares, but I thought that the presentation by Stephen Little and Adam Reynolds of Premaitha (NIPT) at the first ShareProphets seminar was pretty compelling. I certainly view the shares as cheap on the basis of what I heard. To ensure that you get priority booking for future seminars (the next one on 13 October is now booked out but we will start taking bookings for 27 October  next week) register HERE.

Premaitha – Share Options award: Reiterate buy stance

2014-10-03 07:13:46

It sticks in the craw when management award themselves share options at 10p when the share price is 17p. But that is what Premaitha (NIPT) announced yesterday. However

Tip of the week update: Premaitha 40% ahead after 2 weeks – to double from here by Christmas

2014-09-20 07:57:32

AIM listed Premaitha (NIPT)  was our share tip of the week two weeks ago at 10.75p – the shares are now 15.75p but are still a buy from here – we expect them to double by Christmas.

ShareProphets Tip of the Week: Buy Premaitha at 10.75p

2014-09-07 13:11:57

AIM listed Vialogy (VIY) was a perennial dog. That was all meant to change following the reversal of Premaitha into the business at 11p in July. So far the now renamed Premaitha Group (NIPT) has failed to sparkle. The shares are now 10.75p. But after a summer lull we reckon that is all about to change. Big time and soon. Hence it is our share tip of the week.

Search ShareProphets |

Recent Comments |




About ShareProphets

Contact Us

Advertise With Us

Send Us A Tip

Donate


Terms of Service

Privacy Policy

Cookie Policy


Forgot My Password

Forgot My Username

Resend Account Validation Token

Site by Everywhen